ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Year-over-year net income growth rate
5Y CAGR
+67.8%/yr
Long-term compound
Percentile
P97
Near historical high
vs 5Y Ago
13.3x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 281.13% |
| Q3 2025 | 169.18% |
| Q2 2025 | 40.44% |
| Q1 2025 | -86.79% |
| Q4 2024 | 338.71% |
| Q3 2024 | -1.87% |
| Q2 2024 | 101.69% |
| Q1 2024 | -63.85% |
| Q4 2023 | 170.27% |
| Q3 2023 | -5950.63% |
| Q2 2023 | 102.59% |
| Q1 2023 | -3.11% |
| Q4 2022 | -53.50% |
| Q3 2022 | 20.08% |
| Q2 2022 | 69.92% |
| Q1 2022 | -162.35% |
| Q4 2021 | -198.08% |
| Q3 2021 | 67.05% |
| Q2 2021 | 33.98% |
| Q1 2021 | 0.47% |
| Q4 2020 | 21.14% |
| Q3 2020 | -100.90% |
| Q2 2020 | 52.13% |
| Q1 2020 | -65.97% |
| Q4 2019 | -26.34% |
| Q3 2019 | 23.59% |
| Q2 2019 | 35.59% |
| Q1 2019 | -30.25% |
| Q4 2018 | -5.40% |
| Q3 2018 | 1.78% |
| Q2 2018 | -16.52% |
| Q1 2018 | 21.16% |
| Q4 2017 | -5.55% |
| Q3 2017 | 3.25% |
| Q2 2017 | 23.23% |
| Q1 2017 | -11.62% |
| Q4 2016 | -9.89% |
| Q3 2016 | -0.41% |
| Q2 2016 | -43.33% |
| Q1 2016 | -8.69% |